Eisai is expanding the scope of its cancer drug pipeline through a partnership with Bliss Biopharmaceutical, whose lead program addresses a hot oncology target that makes it a potential competitor to a blockbuster AstraZeneca product.
Under the collaboration agreement announced Monday,…
Source: medcitynews.com – Read more

Microsoft Teams To Block Screen Capture During Meetings
Microsoft will launch a “Prevent Screen Capture” feature for Teams in July 2025 to block unauthorized screenshots during meetings, addressing a key vulnerability. The feature